Related Experiment Video
Updated: Jun 12, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
Published on: October 10, 2025
Reversible posterior encephalopathy syndrome associated with bortezomib
E Terwiel1, R Hanrahan, C Lueck
1Department of Haematology, The Canberra Hospital, Woden, Australian Capital Territory, Australia.
Abstract:
Reversible posterior encephalopathy (RPES) is an uncommon neurological syndrome that is being increasingly reported in association with anti-neoplastic therapies. The first case of reversible posterior encephalopathy associated with the proteosome inhibitor bortezomib is described and the reported experience of the occurrence of RPES with other antineoplastic therapies reviewed. Dysregulation of cerebral vasomotor autoregulation is postulated as the underlying pathophysiology in this case of bortezomib associated RPES.
Related Concept Videos
Hepatic Encephalopathy
Cerebral Edema ll: Pathophysiology
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Treatment Resistent Cancers
Cytotoxic Edema: Pathophysiology
